Safety of platelet rich plasma injection for muscle strai
Phase 1
- Conditions
- muscle strain
- Registration Number
- JPRN-UMIN000029278
- Lead Sponsor
- Department of Orthopaedics Surgery, Faculty of Medicine, University of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
a history of infectious disease and systemic disorders such as diabetes, rheumatoid arthritis, hematological diseases (coagulopathy), severe cardiovascular diseases, infections, or immunodepression; therapy with anticoagulants or an anti-aggregating agent; use of non-steroidal anti-inflammatory drugs 2 weeks before blood sampling; and hemoglobin levels <10 g/dL.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse events occurring during platelet-rich plasma use and observation period and its details
- Secondary Outcome Measures
Name Time Method Clinical outcome after using platelet-rich plasma, time course change with MRI